HNGE logo

HNGE

Hinge Health, Inc.NYSEHealthcare
$38.98+1.27%ClosedMarket Cap: $3.07B

As of 2026-04-06

Valuation

View Details

P/E (TTM)

PEG

P/B

8.23

P/S

5.25

EV/EBITDA

-5.48

DCF Value

$-147.37

FCF Yield

5.4%

Div Yield

0.0%

Margins & Returns

Gross Margin

79.6%

Operating Margin

-92.4%

Net Margin

-89.9%

ROE

-132.2%

ROA

-70.9%

ROIC

-140.6%

Financials

View All
PeriodRevenueNet IncomeEPS
Q4 2025$170.7M$32.1M$0.37
FY 2025$587.9M$-528.3M$-5.19
Q3 2025$154.2M$-1.8M$-0.02
Q2 2025$139.1M$-575.7M$-7.38

Analyst Ratings

View All
RBC CapitalOutperform
2026-03-11
CitizensMarket Outperform
2026-02-11
Evercore ISI GroupOutperform
2026-02-11
Canaccord GenuityBuy
2026-02-11
BarclaysOverweight
2026-02-11

Trading Activity

Insider Trades

View All
Mecklenburg Gabriel M.I.director, other: Exec. Chairman & Co-Founder
SellThu Apr 02
Mecklenburg Gabriel M.I.director, other: Exec. Chairman & Co-Founder
SellThu Apr 02
Mecklenburg Gabriel M.I.director, other: Exec. Chairman & Co-Founder
SellThu Apr 02
Pursley Jamesofficer: President
SellWed Apr 01
Budge Jamesofficer: Chief Financial Officer
SellWed Apr 01

Company Info

Sector

Healthcare

Industry

Country

US

Exchange

NYSE

Beta

1.75

Hinge Health, Inc. develops health care software for joint and muscle health. The company designs its platform to address a musculoskeletal care, acute injury, chronic pain, and post-surgical rehabilitation. It also provides various administrative and operations support services. The company was founded in 2012 and is headquartered in San Francisco, California.

Peers